Corrigendum to "The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy" Biomed. Pharmacother. 165 (2023) 114893
Biomed Pharmacother. 2024 Feb:171:116135.
doi: 10.1016/j.biopha.2024.116135.
Epub 2024 Jan 9.
1 Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, Jilin Province 133002, China.
2 Chronic diseases research center, Dalian University College of Medicine, Dalian, Liaoning, 116622, China.
3 Chronic diseases research center, Dalian University College of Medicine, Dalian, Liaoning, 116622, China; Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning 116001, China.
4 Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, Jilin Province 133002, China; Chronic diseases research center, Dalian University College of Medicine, Dalian, Liaoning, 116622, China. Electronic address: zhangqinggao@dlu.edu.cn.